Osaic Holdings
TCRT icon

Osaic Holdings’s Alaunos Therapeutics TCRT Stock Holding History

Osaic Holdings’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.91K Sell
1,731
-48
-3% -$123 ﹤0.01% 7047
2026
Q1 		$5.08K Buy
1,779
+703
+65% +$2.1K ﹤0.01% 6670
2025
Q4 		$3.47K Sell
1,076
-89
-8% -$288 ﹤0.01% 6882
2025
Q3 		$2.81K Buy
1,165
+470
+68% +$1.34K ﹤0.01% 7024
2025
Q2 		$3.36K Sell
695
-25
-3% -$75 ﹤0.01% 6747
2025
Q1 		$1.05K Sell
720
-140
-16% -$229 ﹤0.01% 6801
2024
Q4 		$1.63K Sell
860
-7
-0.8% -$16 ﹤0.01% 6690
2024
Q3 		$2.78K Sell
867
-1,562
-64% -$5.61K ﹤0.01% 6479
2024
Q2 		$17K Sell
2,429
-934
-28% -$11.1K ﹤0.01% 5456
2024
Q1 		$60.9K Sell
3,363
-348
-9% -$6.96K ﹤0.01% 4602
2023
Q4 		$39.4K Sell
3,711
-495
-12% -$5.96K ﹤0.01% 5059
2023
Q3 		$83.2K Buy
4,206
+136
+3% +$5.86K ﹤0.01% 4640
2023
Q2 		$311K Sell
4,070
-12
-0.3% -$971 ﹤0.01% 3553
2023
Q1 		$386K Buy
4,082
+400
+11% +$38.1K ﹤0.01% 3314
2022
Q4 		$358K Sell
3,682
-203
-5% -$29.4K ﹤0.01% 3348
2022
Q3 		$1M Buy
3,885
+36
+0.9% +$10.5K ﹤0.01% 2222
2022
Q2 		$716K Buy
3,849
+64
+2% +$6.12K ﹤0.01% 2591
2022
Q1 		$452K Buy
3,785
+1,009
+36% +$130K ﹤0.01% 3318
2021
Q4 		$453K Sell
2,776
-217
-7% -$47.7K ﹤0.01% 3160
2021
Q3 		$817K Buy
2,993
+703
+31% +$215K ﹤0.01% 2533
2021
Q2 		$906K Sell
2,290
-16
-0.7% -$7.47K ﹤0.01% 2456
2021
Q1 		$1.25M Buy
2,306
+470
+26% +$293K ﹤0.01% 2029
2020
Q4 		$694K Buy
1,836
+597
+48% +$237K ﹤0.01% 2362
2020
Q3 		$469K Sell
1,239
-48
-4% -$21.2K ﹤0.01% 2488
2020
Q2 		$633K Buy
1,287
+315
+32% +$140K ﹤0.01% 2141
2020
Q1 		$367K Buy
+972
New +$503K ﹤0.01% 2349

Other funds holding TCRT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Osaic Holdings's TCRT Position: Q2 2026 in Review

Osaic Holdings reduced its Alaunos Therapeutics (TCRT) stake by 2.7% in Q2 2026, selling an estimated $123 and leaving 1,731 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #7047.

Osaic Holdings first reported a position in TCRT in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.25M in Q1 2021. 29 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.

  • Osaic Holdings held 1,731 shares of Alaunos Therapeutics worth $3.91K as of Q2 2026.
  • Osaic Holdings sold 48 Alaunos Therapeutics shares in Q2 2026, an estimated $123.
  • Alaunos Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7047 holding.
  • Osaic Holdings first reported a position in Alaunos Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Alaunos Therapeutics position peaked at $1.25M in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.